Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McDonald, S. P.
Right arrow Articles by Russ, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDonald, S. P.
Right arrow Articles by Russ, G. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 2212-2219
© 2002 European Renal Association-European Dialysis and Transplant Association

Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991–2001

Stephen P. McDonald and Graeme R. Russ

ANZDATA Registry, Adelaide, Australia

Background. Comparison of mortality rates after kidney transplantation with those treated by dialysis is an important factor is assessing treatment options, but is subject to many pitfalls in selection of appropriate control groups, in particular allowing for varying post-operative risk, and recent changes in mortality rates with better immunosuppression and dialysis techniques. We examined the outcomes following cadaveric renal transplantation and compared them with an appropriate control group of dialysis patients, using contemporary national data from Australia and New Zealand and appropriate statistical methods. In particular, we explicitly addressed the changing risks following transplantation, and looked at both younger (low-risk) and older (higher-risk) recipients, and examined the effect of attribution of deaths in the early period following loss of transplant function to the risk of transplantation.

Methods. We performed a cohort study, initially including 11 560 people aged 15–65 years who began treatment for end-stage renal disease in Australia or New Zealand between 1991 and 2000. Of these, 5144 were recorded at least once as on an active cadaveric transplant waiting list. Survival was analysed with Cox regression, including time-dependent covariates to allow for the violation of proportional hazards with changing mortality risks post-operatively. We also performed stratified analyses on low-risk recipients (<50 years, without co-morbidity) and older recipients.

Results. There was a clear difference in survival between those on the active transplant waiting list and those not listed. Of those who were on the cadaveric transplant waiting list, 2362 (46%) were transplanted in the period to 30 September 2001. Cadaveric transplantation was associated with an initial increase in mortality [during the first 3 months post-transplantation, adjusted HR 2.0 (1.5–2.7), P<0.001]. This fell below the dialysis group at 6 months [adjusted HR 0.27 (0.16–0.47), P<0.001] and from 12 months post-transplantation, the reduction in risk of mortality was ~80% [adjusted HR 0.19 (0.15–0.24), P<0.001]. A secondary analysis showed the excess risk attributed to the period immediately following transplantation was actually due to deaths in the 60 days after loss of transplant function rather than those occurring with a functioning graft.

Conclusions. As well as improved quality of life, cadaveric renal transplantation in Australia and New Zealand is associated with a survival advantage compared with those remaining on the waiting list.

Keywords: cadaveric kidney transplants; end-stage renal disease; haemodialysis; peritoneal dialysis

Correspondence and offprint requests to: ANZDATA Registry, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville South, SA 5011, Australia. Email: stephenm{at}anzdata.org.au

Conflict of interest. Dr McDonald's salary is supported by a grant from AMGEN Australia to the ANZDATA Registry. AMGEN played no part in the Registry operations or preparation or submission of this report.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Bayat, M. Kessler, S. Briancon, and L. Frimat
Survival of transplanted and dialysed patients in a French region with focus on outcomes in the elderly
Nephrol. Dial. Transplant., September 11, 2009; (2009) gfp469v1.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, et al.
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
Ann Rheum Dis, February 1, 2008; 67(2): 195 - 205.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. W. Johnson, D. W. Mudge, M. O. Kaisar, S. B. Campbell, C. M. Hawley, N. M. Isbel, D. Wall, A. Griffin, J. Preston, and D. L. Nicol
Deceased donor renal transplantation--does side matter?
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2583 - 2588.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. P. McDonald, J. C. Craig, and the Australian and New Zealand Paediatric Nephrolo
Long-Term Survival of Children with End-Stage Renal Disease
N. Engl. J. Med., June 24, 2004; 350(26): 2654 - 2662.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.